We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+13.07%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$624M
AUM Growth
+$28.8M
Cap. Flow
-$28M
Cap. Flow %
-4.49%
Top 10 Hldgs %
62.73%
Holding
38
New
5
Increased
9
Reduced
19
Closed
5

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$36.9M
2
VTRS icon
Viatris
VTRS
+$23.1M
3
TAK icon
Takeda Pharmaceutical
TAK
+$13M
4
BMY icon
Bristol-Myers Squibb
BMY
+$11.5M
5
GILD icon
Gilead Sciences
GILD
+$9.6M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.8M
2
SHPG
Shire pic
SHPG
+$21.9M
3
CELG
Celgene Corp
CELG
+$16.9M
4
ELV icon
Elevance Health
ELV
+$9.98M
5
ABT icon
Abbott
ABT
+$9.94M

Sector Composition

Rank Sector Weight
1 Healthcare 98.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$64.8M 10.39%
1,358,470
+230,000
+20% +$11.5M
ABT icon
2
Abbott
ABT
$175B
$61M 9.79%
763,676
-133,600
-15% -$9.94M
BSX icon
3
Boston Scientific
BSX
$65.4B
$42.8M 6.86%
1,115,174
-193,200
-15% -$7.38M
GILD icon
4
Gilead Sciences
GILD
$167B
$37.6M 6.03%
578,737
+144,380
+33% +$9.6M
BAX icon
5
Baxter International
BAX
$11.7B
$36.4M 5.84%
448,228
-41,400
-8% -$3.01M
BIIB icon
6
Biogen
BIIB
$30.4B
$35.5M 5.69%
150,200
+117,100
+354% +$36.9M
RVTY icon
7
Revvity
RVTY
$12.3B
$33.1M 5.3%
343,081
-16,000
-4% -$1.44M
NUVA
8
DELISTED
NuVasive, Inc.
NUVA
$30.6M 4.91%
538,625
+64,702
+14% +$3.44M
BIO icon
9
Bio-Rad Laboratories Class A
BIO
$8.15B
$26.7M 4.28%
87,397
-9,300
-10% -$2.51M
A icon
10
Agilent Technologies
A
$37.1B
$22.5M 3.61%
280,351
-34,700
-11% -$2.63M
INCY icon
11
Incyte
INCY
$23.4B
$22.5M 3.6%
261,293
-75,151
-22% -$6.11M
VTRS icon
12
Viatris
VTRS
$20.1B
$22.4M 3.59%
+790,700
New +$23.1M
IONS icon
13
Ionis Pharmaceuticals
IONS
$8.99B
$19M 3.04%
233,714
-145,707
-38% -$9.4M
QGEN icon
14
Qiagen
QGEN
$8.49B
$16.1M 2.59%
374,384
-9,822
-3% -$395K
CVS icon
15
CVS Health
CVS
$137B
$16.1M 2.58%
298,733
+32,063
+12% +$1.98M
PRGO icon
16
Perrigo
PRGO
$1.48B
$14.8M 2.38%
308,020
+1,200
+0.4% +$56.2K
TAK icon
17
Takeda Pharmaceutical
TAK
$54.8B
$13.2M 2.12%
+647,451
New +$13M
ELV icon
18
Elevance Health
ELV
$80.9B
$11.2M 1.8%
39,013
-34,500
-47% -$9.98M
MRK icon
19
Merck
MRK
$315B
$9.93M 1.59%
125,081
-358,095
-74% -$26.8M
PDCO
20
DELISTED
Patterson Companies, Inc.
PDCO
$9.84M 1.58%
450,363
-31,900
-7% -$707K
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
$9.43M 1.51%
379,777
+44,200
+13% +$1.11M
PTLA
22
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$8.83M 1.42%
254,501
-30,200
-11% -$871K
UHS icon
23
Universal Health Services
UHS
$9.15B
$8.41M 1.35%
62,906
-15,000
-19% -$1.98M
CAH icon
24
Cardinal Health
CAH
$53.5B
$7.83M 1.26%
162,635
-43,700
-21% -$2.19M
PTCT icon
25
PTC Therapeutics
PTCT
$6.52B
$7.33M 1.18%
+194,743
New +$6.54M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2019 Portfolio in Review

As of Q1 2019, Sector Gamma AS held 38 positions worth $624M, up 4.8% from $595M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sector Gamma AS withdrew a net $28M in Q1 2019, closing 5 positions and reducing 19 holdings. Its most notable exit was Shire pic, an estimated $21.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Viatris worth $22.4M.

  • Sector Gamma AS's largest Q1 2019 buy was Viatris: 790,700 shares worth $22.4M.
  • Sector Gamma AS added most to Biogen in Q1 2019, an estimated $36.9M increase.
  • Sector Gamma AS's biggest Q1 2019 reduction was Merck, cutting an estimated $26.8M.
  • Sector Gamma AS fully exited Shire pic in Q1 2019, selling an estimated $21.9M.
  • Sector Gamma AS's ten largest holdings make up 63% of its $624M portfolio in Q1 2019.
  • Sector Gamma AS opened 5 new positions and closed 5 in Q1 2019.
  • Sector Gamma AS's portfolio value rose 4.8% quarter-over-quarter to $624M.

Based on Sector Gamma AS's 13F filing for Q1 2019, filed 13 May 2019.